TURNING NOVEL DISCOVERIES INTO
INNOVATIVE HEALTH CARE SOLUTIONS.

KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the United States health care system $20 billion per year.

PRODUCTS »
Product Pipeline |
DispersinB® |
Aledex® |
CSP |
KBI Antibacterial Disinfectant

KBI Antibacterial Disinfectant (KBI)

KBI contains a unique, patented, antimicrobial-antibiofilm combination comprised of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP). CHX has broad-spectrum antimicrobial activity and SMP has broad-spectrum antipolysaccharide (biofilm) activity in addition to antimicrobial action.

How KBI works

Breakdown the Polysaccharide (biofilm), exposing the bacteria
Killing the now exposed bacteria with the antimicrobial agent

Disrupting the environment bacteria live in is critical in order to assure the embedded bacteria are killed.

DIN 02374463

KBI Inquires:
Jason Leibert
Business Development Manager
jleibert@kanebiotech.com

Download KBI Product Information